Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balant L., Zahnd G. R., Weber F., Fabre J. Behaviour of glibenclamide on repeated administration to diabetic patients. Eur J Clin Pharmacol. 1977;11(1):19–25. doi: 10.1007/BF00561783. [DOI] [PubMed] [Google Scholar]
- Cooper G. L. The safety of fluoxetine--an update. Br J Psychiatry Suppl. 1988 Sep;(3):77–86. [PubMed] [Google Scholar]
- Gray D. S., Fujioka K., Devine W., Bray G. A. Fluoxetine treatment of the obese diabetic. Int J Obes Relat Metab Disord. 1992 Mar;16(3):193–198. [PubMed] [Google Scholar]
- Jackson J. E., Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. Drugs. 1981 Oct;22(4):295–320. doi: 10.2165/00003495-198122040-00003. [DOI] [PubMed] [Google Scholar]
- Lear J., Burden A. C. Fluoxetine side-effects mimicking hypoglycaemia. Lancet. 1992 May 23;339(8804):1296–1296. doi: 10.1016/0140-6736(92)91624-h. [DOI] [PubMed] [Google Scholar]
- O'Kane M., Wiles P. G., Wales J. K. Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med. 1994 Jan-Feb;11(1):105–110. doi: 10.1111/j.1464-5491.1994.tb00238.x. [DOI] [PubMed] [Google Scholar]
- Potter van Loon B. J., Radder J. K., Frölich M., Krans H. M., Zwinderman A. H., Meinders A. E. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord. 1992 Feb;16(2):79–85. [PubMed] [Google Scholar]
- Rogers H. J., Spector R. G., Morrison P. J., Bradbrook I. D. Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. Diabetologia. 1982 Jul;23(1):37–40. doi: 10.1007/BF00257728. [DOI] [PubMed] [Google Scholar]
- Service F. J. Hypoglycemic disorders. N Engl J Med. 1995 Apr 27;332(17):1144–1152. doi: 10.1056/NEJM199504273321707. [DOI] [PubMed] [Google Scholar]
- Wernicke J. F. The side effect profile and safety of fluoxetine. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):59–67. [PubMed] [Google Scholar]